Bevacizumab Effect on Blood Velocity

The Effect of Intravitreal Bevacizumab (Avastin) Injection on Retinal Blood-Flow Velocity in Patients With Choroidal Neovascularization

Retinal blood flow velocity is affected by Bevacizump intravitreal injection. This effect is correlated to treatment success.

The purpose of the study was to carry out a pilot study on the short-term effect of intravitreal Bevacizumab (Avastin) injection on retinal blood-flow velocity and test whether the short-term haemodynamic changes could predict the longer term clinical result of the treatment.

Inclusion Criteria:

• Patients with CNV receiving Bevacizumab intravitreal injection

Exclusion Criteria:

• Candidates in whom the retina could not be seen clearly because of media opacity or a poorly dilating pupil